PPD
Ripal Suthar is a seasoned Regulatory Affairs Specialist with a strong background in developing and executing regulatory strategies across various regions, including the MHRA, EU, Canada, South Africa, and GCC at PPD since July 2021. Previously, Ripal served as a Regulatory Affairs Executive at Nivagen Pharmaceuticals, Inc., where responsibilities included preparing and submitting ANDAs in eCTD format and managing regulatory compliance. Prior experience also includes working as a Regulatory Affairs Senior Consultant at DXC Technology, where Ripal built submissions for NDA and IND, and as a Jr. Officer at Apothecon Pharmaceutical, focusing on DMF, ASMF, and ANDA submissions. Educational qualifications include a Master of Pharmacy in Quality Assurance and Regulatory Affairs from L.J. Institute Of Pharmacy and a Bachelor of Pharmacy from Dharmaj Degree Pharmacy College.
This person is not in any offices
PPD
22 followers
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Their customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 23,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development to deliver life-changing therapies that improve health.